Injective (INJ) is currently trading at $3.05, experiencing a 24-hour decline of 2.61%. The price action reflects a daily range between $2.98 and $3.14, indicating a tight trading range of 0.16%, which suggests a lack of volatility in the short term.

The trading volume stands at approximately 45.3 million, which represents 14.84% of the market cap, highlighting a healthy level of liquidity. However, the moving averages indicate mixed sentiment; the 8-period SMA is at $3.04 with a slight increase, while the longer-term SMAs reflect bearish momentum, particularly the 144 SMA at $3.11, down 1.97%.

The RSI indicators support the bearish outlook, with the 1-hour RSI at 40, suggesting that INJ is nearing oversold territory but not quite there. Over the past week, the 7-day RSI is at 45, and the asset has lost over 5.21% in price, indicating continued selling pressure.

From a longer-term perspective, INJ has experienced notable declines, with a 30-day price change of -12.89%. This trend is concerning given the significant gap from its all-time high of $52.62, suggesting that current prices are substantially undervalued compared to historical performance.

In conclusion, while there are short-term fluctuations, the overall trend indicates bearish momentum with declining moving averages and RSI levels. Based on the current analysis, a Sell rating is appropriate as further downside risk seems plausible in the near term.